Company
Access Vascular
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
9
510(k), De Novo and PMA
Device trials
3
As lead sponsor, any status
Adverse event reports
16
Received Nov 1, 2025 to Nov 20, 2026
Recall records
9
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$51.8M
6 Form D offerings, 2017 to 2023
Equity
$11.2M
Stock sold for cash
Debt and convertible notes
$40.5M
$40.5M of it convertible
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: convertible note, $20.6M raised of $31.6M sought, first sale Oct 13, 2023, 19 investors.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Oct 13, 2023 | Convertible note | $20.6M | $31.6M | 19 | Rule 506(b) | Form D ↗Oct 30, 2023 |
| Oct 6, 2022 | Convertible note | $0 | $10.0M | 2 | Rule 506(b) | Form D ↗Oct 19, 2022 |
| Feb 23, 2021 | Convertible note | $19.9M | $19.9M | 14 | Rule 506(b) | Form D ↗Mar 9, 2021 |
3 more funding rounds with a free account
Company details
From the company's latest Form D.
- Legal name
- Access Vascular, Inc.
- Headquarters
- Bedford, Massachusetts
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Biotechnology
- SEC filer
- CIK 1714846 ↗
Executives, directors and promoters
As listed on the latest Form D.
7 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Access Vascular.
Latest FDA decisions
The 8 newest of 9 since 2015.
K243458 · Decided Aug 1, 2025 · 266 days after receipt
Device type: Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days (LJS) · Hospital Medicine & Nursing
K251212 · Decided Jul 1, 2025 · 74 days after receipt
Device type: Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days (LJS) · Hospital Medicine & Nursing
K244059 · Decided Mar 27, 2025 · 86 days after receipt
Device type: Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days (FOZ) · Hospital Medicine & Nursing
6 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Midline Failures: A Comparison Between a Hydrophilic Biomaterial and Thermoplastic PolyurethaneCompleted
NCT04911842 · 205 participants · Start May 20, 2021 · Primary completion Dec 2, 2021
Device: HydroMID; TPU · For: Midline Catheter
Sites: Romeoville, Illinois
NCT04920929 · 7 participants · Start Jul 15, 2021 · Primary completion Oct 7, 2021
Device: Hydrophilic Biomaterial; Thermoplastic Polyurethane · For: Peripheral ICC
Sites: Royal Oak, Michigan
NCT04656548 · 121 participants · Start Nov 13, 2020 · Primary completion Apr 23, 2021
Device: HydroPICC · For: Peripheral ICC; PICC
Sites: Romeoville, Illinois
Reports received
16
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
6
38% of reports
Injury reports
10
63% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 2 | 0 | 0 |
| Feb 24 | 0 | 2 | 0 | 0 |
| Mar 24 | 0 | 2 | 0 | 0 |
| Apr 24 | 0 | 2 | 0 | 0 |
| May 24 | 0 | 5 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 3 | 0 | 0 |
| Aug 24 | 0 | 1 | 0 | 0 |
| Sep 24 | 0 | 2 | 0 | 0 |
| Oct 24 | 0 | 2 | 0 | 0 |
| Nov 24 | 6 | 0 | 0 | 0 |
| Dec 24 | 3 | 0 | 0 | 0 |
| Jan 25 | 2 | 0 | 0 | 0 |
| Feb 25 | 6 | 0 | 0 | 0 |
| Mar 25 | 2 | 0 | 0 | 0 |
| Apr 25 | 3 | 0 | 0 | 0 |
| May 25 | 2 | 0 | 0 | 0 |
| Jun 25 | 3 | 0 | 0 | 0 |
| Jul 25 | 1 | 0 | 0 | 0 |
| Aug 25 | 1 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 1 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 2 | 0 | 0 | 0 |
| May 26 | 2 | 0 | 0 | 0 |
| Jun 26 | 1 | 4 | 0 | 0 |
| Jul 26 | 1 | 3 | 0 | 0 |
| Aug 26 | 0 | 1 | 0 | 0 |
| Sep 26 | 0 | 1 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
- HYDROMID10
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0114-2024 · Started Aug 31, 2023 · Posted by FDA Oct 13, 2023
Reason given: Specific lots of the Dual Lumen HydroPICC Kits were provided with the incorrect revision of the Instructions For Use (IFU) which do not include the following warnings statement: HydroPICC Dual Lumen Catheter is for adult use only. There is a potential risk to health should the HydroPICC Dual Lumen Catheter be used in...
Cause as FDA categorized it: Error in labeling · Device type: Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days (LJS)
Z-0115-2024 · Started Aug 31, 2023 · Posted by FDA Oct 13, 2023
Reason given: Specific lots of the Dual Lumen HydroPICC Kits were provided with the incorrect revision of the Instructions For Use (IFU) which do not include the following warnings statement: HydroPICC Dual Lumen Catheter is for adult use only. There is a potential risk to health should the HydroPICC Dual Lumen Catheter be used in...
Cause as FDA categorized it: Error in labeling · Device type: Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days (LJS)
Z-1605-2023 · Started Mar 3, 2023 · Posted by FDA May 18, 2023
Reason given: The catheter packaged with specific lots of the HydroPICC Kits and HydroMID Kits have a shorter expiration date than what is listed on the outer kit package.
Cause as FDA categorized it: Labeling mix-ups · Device type: Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days (LJS)
6 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.